Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Independence Blue Cross | Prophylactic Mastectomy, Oophorectomy/Salpingo-Oophorectomy, and HysterectomyPayerPolicy · IBX-COMMERCIAL-11-08-19 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD)PayerPolicy · IBX-COMMERCIAL-11-03-11 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Procedures for the Treatment of AcnePayerPolicy · IBX-COMMERCIAL-11-08-29 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Private Duty NursingPayerPolicy · IBX-COMMERCIAL-02-01-02 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Preventive Care ServicesPayerPolicy · IBX-COMMERCIAL-00-06-02AZ-DDFED56970 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management TreatmentsPayerPolicy · IBX-COMMERCIAL-06-02-44 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pressure-Reducing Support SurfacesPayerPolicy · IBX-COMMERCIAL-05-00-60 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Prescription Lenses and Visual DevicesPayerPolicy · IBX-COMMERCIAL-07-13-13 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Prescription Digital Therapeutics and Mobile-Based Health Management ApplicationsPayerPolicy · IBX-COMMERCIAL-12-00-05 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Preimplantation Genetic Testing (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-06-02-24 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative ServicesPayerPolicy · IBX-COMMERCIAL-00-01-25BU-378CC1E8C5 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative ServicesPayerPolicy · IBX-COMMERCIAL-00-01-25BT-E8C43924DA | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pozelimab-bbfg (Veopoz)PayerPolicy · IBX-COMMERCIAL-08-02-17 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Power Wheelchairs (PWCs), Power-Operated Vehicles (POVs), and Power-Assist System DevicesPayerPolicy · IBX-COMMERCIAL-05-00-54 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Positron Emission Mammography (PEM)PayerPolicy · IBX-COMMERCIAL-09-00-51 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Polatuzumab vedotin-piiq (Polivy)PayerPolicy · IBX-COMMERCIAL-08-01-59 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pneumatic Compression Therapy DevicesPayerPolicy · IBX-COMMERCIAL-05-00-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Physical Medicine and Rehabilitation Services Eligible for Reimbursement Above Capitation to Physical and Occupational Therapy (PT/OT) Providers for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-ServPayerPolicy · IBX-COMMERCIAL-00-03-06 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Photodynamic Therapy (PDT) Using Verteporfin (Visudyne)PayerPolicy · IBX-COMMERCIAL-07-13-05 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Photodynamic Therapy (PDT) Using Porfimer Sodium (Photofrin)PayerPolicy · IBX-COMMERCIAL-07-00-10 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Photodynamic Therapy (PDT) Using Levulan Kerastick or Ameluz (Aminolevulinic Acid HCl [ALA])PayerPolicy · IBX-COMMERCIAL-07-07-03 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pharmacogenetic Testing to Determine Drug Sensitivity (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-06-02-30 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) Therapy (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-06-02-18 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo)PayerPolicy · IBX-COMMERCIAL-08-01-72 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pertuzumab (Perjeta) and related biosimilar pertuzumab-dpzb (Poherdy)PayerPolicy · IBX-COMMERCIAL-08-01-07 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Personalized Vaccines (e.g., Provenge)PayerPolicy · IBX-COMMERCIAL-08-00-95 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Peroral Endoscopic Myotomy (POEM) ProceduresPayerPolicy · IBX-COMMERCIAL-11-03-17 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous Vertebroplasty, Kyphoplasty and Sacroplasty (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-11-14-10 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting of the Extracranial Carotid Artery or Intracranial ArteryPayerPolicy · IBX-COMMERCIAL-11-02-12 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial FibrillationPayerPolicy · IBX-COMMERCIAL-11-02-26 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous Intradiscal Annuloplasty (IDET/PIRFT)PayerPolicy · IBX-COMMERCIAL-11-14-14 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous Image-Guided Lumbar Decompression (PILD) for Spinal StenosisPayerPolicy · IBX-COMMERCIAL-11-15-22 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)PayerPolicy · IBX-COMMERCIAL-05-00-75 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous DiscectomyPayerPolicy · IBX-COMMERCIAL-11-15-15 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound (Independence)PayerPolicy · IBX-COMMERCIAL-11-02-27 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Penpulimab-kcqxPayerPolicy · IBX-COMMERCIAL-08-02-42 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pemetrexed (Pemfexy)PayerPolicy · IBX-COMMERCIAL-08-00-87 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pembrolizumab and berahyaluronidase alfa-pmph (Keytruda QLEX)PayerPolicy · IBX-COMMERCIAL-08-02-49 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pembrolizumab (Keytruda)PayerPolicy · IBX-COMMERCIAL-08-01-63 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pelvic Floor Stimulation as a Treatment of IncontinencePayerPolicy · IBX-COMMERCIAL-07-12-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pegloticase (Krystexxa)PayerPolicy · IBX-COMMERCIAL-08-01-02 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pediatric Intensive Day Feeding ProgramPayerPolicy · IBX-COMMERCIAL-10-00-03 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Patisiran (Onpattro) and vutrisiran (Amvuttra)PayerPolicy · IBX-COMMERCIAL-08-01-50 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Patient LiftsPayerPolicy · IBX-COMMERCIAL-05-00-42 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Panniculectomy, Abdominoplasty, Abdominal Lipectomy, and Other Excisions of Redundant SkinPayerPolicy · IBX-COMMERCIAL-11-08-06 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Palivizumab (Synagis)PayerPolicy · IBX-COMMERCIAL-08-00-22 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pain Management of Peripheral Nerves by InjectionPayerPolicy · IBX-COMMERCIAL-07-03-27 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension)PayerPolicy · IBX-COMMERCIAL-08-00-90 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Outpatient Short-Term Rehabilitation Services Included in CapitationPayerPolicy · IBX-COMMERCIAL-00-03-03 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Outpatient Physical Medicine, Rehabilitation, and Habilitation ServicesPayerPolicy · IBX-COMMERCIAL-10-03-01 | New policy |
|---|